Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $31,057,203 |
Sells | 234 | $215,215,543 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 18 Sep 2023 | Sale | 1,290 | 9.41 | 12,139 | D |
20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Sep 2023 | Sale | 1,436 | 9.41 | 13,513 | D |
20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 18 Sep 2023 | Sale | 12,032 | 9.41 | 113,221 | D |
20 Sep 2023 16:48 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 18 Sep 2023 | Sale | 2,672 | 9.41 | 25,144 | D |
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 18 Sep 2023 | Sale | 1,261 | 9.41 | 11,866 | D |
02 Nov 2023 17:16 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 02 Nov 2023 | Sale | 9,939 | 7.4 | 73,549 | D |
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 04 Dec 2023 | Sale | 681 | 12.01 | 8,179 | D |
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 06 Dec 2023 | Sale | 1,872 | 12.01 | 22,483 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Dec 2023 | Sale | 1,245 | 10.72 | 13,346 | D |
12 Dec 2023 17:35 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 11 Dec 2023 | Sale | 1,380 | 10.72 | 14,794 | D |
12 Dec 2023 17:32 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Dec 2023 | Sale | 1,467 | 10.72 | 15,726 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 11 Dec 2023 | Sale | 7,585 | 10.72 | 81,311 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Dec 2023 | Sale | 1,688 | 10.72 | 18,095 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Dec 2023 | Sale | 1,616 | 10.72 | 17,324 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Dec 2023 | Sale | 978 | 10.55 | 10,318 | D |
14 Dec 2023 16:59 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 14 Dec 2023 | Sale | 2,376 | 12.02 | 28,560 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 02 Jan 2024 | Sale | 11,900 | 13.1 | 155,890 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 16,026 | 20.5 | 328,533 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 19,775 | 19.03 | 376,318 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 03 Jan 2024 | Sale | 15,382 | 18.34 | 282,106 | D |
04 Jan 2024 21:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 03 Jan 2024 | Sale | 13,000 | 18.81 | 244,530 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 10,300 | 19.03 | 196,009 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 7,691 | 18.34 | 141,053 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 5,361 | 20.5 | 109,900 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 24,583 | 19.05 | 468,306 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 15,382 | 18.34 | 282,106 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 04 Jan 2024 | Sale | 38,301 | 19.05 | 729,634 | D |
04 Jan 2024 21:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 04 Jan 2024 | Sale | 180,235 | 18.4 | 3,316,324 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 04 Jan 2024 | Sale | 2,009 | 18.04 | 36,242 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 04 Jan 2024 | Sale | 42,453 | 18.13 | 769,673 | D |
11 Jan 2024 16:31 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director , 10% | 09 Jan 2024 | Purchase | 1,428,571 | 17.5 | 24,999,992 | I |
11 Jan 2024 16:31 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director , 10% | 09 Jan 2024 | Purchase | 285,714 | 17.5 | 4,999,995 | I |
26 Jan 2024 19:49 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 26 Jan 2024 | Sale | 100 | 25 | 2,500 | D |
26 Jan 2024 19:47 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 26 Jan 2024 | Sale | 13,000 | 24.34 | 316,420 | D |
26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 178 | 25.14 | 4,475 | D |
26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 19,822 | 24.52 | 486,035 | D |
14 Feb 2024 16:27 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Feb 2024 | Sale | 5,493 | 25.07 | 137,710 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | I |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | I |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | I |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | I |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | D |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | D |
28 Feb 2024 17:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 28 Feb 2024 | Sale | 407 | 25 | 10,175 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 29 Feb 2024 | Sale | 3,429 | 27.5 | 94,298 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 29 Feb 2024 | Sale | 4,268 | 27.5 | 117,370 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 29 Feb 2024 | Sale | 5,520 | 27.5 | 151,800 | D |
05 Mar 2024 17:07 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND I, L.P. | 10% | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)